David jimÉnez joins moderna as u.s. general manager

Cambridge, ma / accesswire / november 17, 2022 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced the appointment of david jimÉnez as general manager, united states, effective november 21, 2022. mr. jimÉnez will be responsible for commercial efforts in the united states, reporting to arpa garay, moderna's chief commercial officer.
MRNA Ratings Summary
MRNA Quant Ranking